Literature DB >> 24154751

[Differential diagnosis for detection of hyphae in tissue].

K Tintelnot1.   

Abstract

Usually the detection of hyphae in tissue is unmistakable evidence of a deep mycosis requiring antimycotic treatment. Micromorphology alone rarely allows a specific diagnosis, thus confusion is possible between Candida, Aspergillus, Alternaria and Fusarium species or several other fungal agents. If broad, nearly non-septated hyphae are detected histologically mucormycosis can be suspected. Detection of hyphae in tissue is always a cause for concern because therapeutic consequences must follow. Because therapeutic strategies may differ depending on the specific fungal agent, a suspected diagnosis should be supplemented by other methods, e.g. culture of unfixed specimens, by immunohistology or molecular biological methods.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154751     DOI: 10.1007/s00292-013-1829-3

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

Review 1.  Infections due to emerging and uncommon medically important fungal pathogens.

Authors:  T J Walsh; A Groll; J Hiemenz; R Fleming; E Roilides; E Anaissie
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

Review 2.  Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist.

Authors:  Josep Guarro; A Serda Kantarcioglu; Regine Horré; Juan Luis Rodriguez-Tudela; Manuel Cuenca Estrella; Juan Berenguer; G Sybren de Hoog
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

Review 3.  DNA and the classical way: identification of medically important molds in the 21st century.

Authors:  S Arunmozhi Balajee; Lynne Sigler; Mary E Brandt
Journal:  Med Mycol       Date:  2007-09       Impact factor: 4.076

4.  Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

Authors:  T Lehrnbecher; C Frank; K Engels; S Kriener; A H Groll; D Schwabe
Journal:  J Infect       Date:  2010-07-31       Impact factor: 6.072

5.  Organ-specific variation in the morphology of the fungomas (fungus balls) of Pseudallescheria boydii. Development within necrotic host tissue.

Authors:  D A Schwartz
Journal:  Arch Pathol Lab Med       Date:  1989-05       Impact factor: 5.534

6.  Ochroconis gallopavum infection in a lung transplant recipient: report of a case.

Authors:  E I Brokalaki; U Sommerwerck; E H von Heinegg; U Hillen
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

7.  Sporotrichoid phaeohyphomycosis due to Alternaria infectoria.

Authors:  R Gerdsen; M Uerlich; G S De Hoog; T Bieber; R Horré
Journal:  Br J Dermatol       Date:  2001-09       Impact factor: 9.302

Review 8.  Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species.

Authors:  Peter C Iwen; Stephanie D Schutte; Diana F Florescu; Rhonda K Noel-Hurst; Lynne Sigler
Journal:  Med Mycol       Date:  2012-04-23       Impact factor: 4.076

9.  Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin.

Authors:  Felipe Suarez; Gaelle Olivier; Dea Garcia-Hermoso; Edouard Randriamalala; David Ghez; Julie Bruneau; Catherine Kauffmann-Lacroix; Marie-Elisabeth Bougnoux; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

Review 10.  A review of German Scedosporium prolificans cases from 1993 to 2007.

Authors:  K Tintelnot; G Just-Nübling; R Horré; B Graf; I Sobottka; M Seibold; A Haas; U Kaben; G S De Hoog
Journal:  Med Mycol       Date:  2009-03-18       Impact factor: 4.076

View more
  1 in total

Review 1.  [Cutaneous infection due to Fusarium oxysporum in a female diabetic: molecular biological detection of the mold from formalin-fixed paraffin embedded tissue using sequencing of the ITS region of the rDNA].

Authors:  P Nenoff; A Bernhardt; K Tintelnot; V Kingreen; P Dücker; M Cofalka; J Schaller
Journal:  Hautarzt       Date:  2014-06       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.